The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of Hispanic and non-Hispanic white pediatric and young adult patients with B-cell acute lymphoblastic leukemia after commercial tisagenlecleucel.
 
Panayiotis Vandris
No Relationships to Disclose
 
Karen Chao
No Relationships to Disclose
 
Christina Baggott
No Relationships to Disclose
 
Christine L. Phillips
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis; Novartis
 
Muna Qayed
Consulting or Advisory Role - Medexus Pharmaceuticals; Mesoblast; Novartis
Travel, Accommodations, Expenses - Novartis
 
Jenna Rossoff
Consulting or Advisory Role - Novartis
 
Stephanie J. Si Lim
No Relationships to Disclose
 
Lena E. Winestone
Stock and Other Ownership Interests - Merck; Pfizer
 
Heather E. Stefanski
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
 
Julie-An M. Talano
Consulting or Advisory Role - Novartis
 
Steven Margossian
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis
 
Michael R. Verneris
Stock and Other Ownership Interests - Fate Therapeutics
Honoraria - Jazz Pharmaceuticals; Novartis
Patents, Royalties, Other Intellectual Property - patent to make innate lymphiod cells. It is not licensed.
 
Gary Douglas Myers
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst)
 
Nicole A. Karras
No Relationships to Disclose
 
Patrick A. Brown
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Kite, a Gilead company; Kura Oncology; Novartis; SERVIER; Takeda
 
Prakash Satwani
Consulting or Advisory Role - Mesoblast; Takeda
Speakers' Bureau - SOBI
 
Crystal Mackall
Leadership - Syncopation Life Sciences
Stock and Other Ownership Interests - Alimera Sciences; Apricity Health; Ensoma; Lyell Immunopharma; Mammoth Biosciences; Syncopation Life Sciences; Vor Biopharma
Consulting or Advisory Role - Alimera Sciences; Apricity Health; Bristol-Myers Squibb; Ensoma; GlaxoSmithKline; immatics; Lyell Immunopharma; Mammoth Biosciences; Nektar; NeoImmuneTech; NeoImmuneTech; PACT Pharma; Syncopation Life Sciences; Vor Biopharma
Research Funding - Lyell Immunopharma
Patents, Royalties, Other Intellectual Property - I am an inventor on numerous patents related to chimeric antigen receptor therapeutics and received royalties from NIH for the CD22-CAR patent licensed to Juno therapeutics.
Travel, Accommodations, Expenses - Nektar; NeoImmuneTech; Roche
Other Relationship - Lyell Immunopharma; Syncopation Life Sciences
 
Kevin J. Curran
Honoraria - Novartis
Consulting or Advisory Role - Mesoblast; Novartis; Novartis
Research Funding - Celgene; Juno Therapeutics; Novartis
 
Theodore Willis Laetsch
Consulting or Advisory Role - Advanced Microbubbles; AI Therapeutics; Aptitude Health; Bayer; Cellectis; Clinical Education Alliance; Deciphera; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Med Learning Group; Medscape; Novartis; Physicans' Education Resource; Y-mAbs Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); Foundation Medicine (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst); Turning Point Therapeutics (Inst)
 
Liora M. Schultz
Consulting or Advisory Role - Novartis